top of page

Our human kidney S9 fraction provides a versatile in vitro system for evaluating both Phase I and Phase II metabolism in renal tissue. Isolated from human kidney homogenate, this fraction contains both cytosolic and microsomal enzymes, making it ideal for studying a broad range of metabolic reactions, including oxidation, reduction, hydrolysis, glucuronidation, and sulfation.

Designed for use in drug metabolism, clearance prediction, and nephrotoxicity assessment, the human kidney S9 fraction offers a reliable and physiologically relevant model for investigating extrahepatic biotransformation in drug discovery and development

Human Kidney S9 Fraction

$54.00Price
  • 1 ml 5 mg/ml

    UGT and CYP4A characterization

  • Renal drug metabolism studies

    Drug-drug interaction assessment

    Nephrotoxicity prediction

bottom of page